Recursion Pharmaceuticals Stock Forecast

Sell candidate since Aug 07, 2026

The Recursion Pharmaceuticals, Inc. stock price gained 1.26% on the last trading day (Friday, 7th Aug 2026), rising from $3.18 to $3.22. During the last trading day the stock fluctuated 2.83% from a day low at $3.18 to a day high of $3.27. The price has risen in 7 of the last 10 days and is up by 8.78% over the past 2 weeks. Volume fell on the last day by -5 million shares and in total, 9 million shares were bought and sold for approximately $30.13 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Recursion Pharmaceuticals, Inc. stock with a 90% probability to be traded between $2.83 and $3.95 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

RXRX Signals & Forecast

There are mixed signals in the stock today. The Recursion Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.29. On a fall, the stock will find some support from the short-term average at $3.16. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, August 04, 2026, and so far it has fallen -2.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Recursion Pharmaceuticals, Inc. stock

Recursion Pharmaceuticals, Inc. finds support from accumulated volume at $3.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0900 between high and low, or 2.83%. For the last week, the stock has had daily average volatility of 5.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RXRX) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Recursion Pharmaceuticals, Inc. to open at $3.22, and during the day (based on 14 day Average True Range), to move between $3.13 and $3.31, which gives a possible trading interval of +/-$0.187 (+/-6.00%) up or down from last closing price. If Recursion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 6.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.18 (1.24%) than the resistance at $3.52 (9.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Recursion Pharmaceuticals, Inc. stock A Buy?

Recursion Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.400 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $3.22 ( 0.104%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk